Targeting cancer cell metabolism in pancreatic adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of cancer death by 2030. Current therapeutic options are limited, warranting an urgent need to explore innovative treatment strategies. Due to specific microenvironment constraints including an extensive desmoplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Romain, Neuzillet, Cindy, Tijeras-Raballand, Annemilaï, Faivre, Sandrine, de Gramont, Armand, Raymond, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627277/
https://www.ncbi.nlm.nih.gov/pubmed/26164081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627277/
https://www.ncbi.nlm.nih.gov/pubmed/26164081

Ejemplares similares